Scale and scope in drug development: Unpacking the advantages of size in pharmaceutical research

Journal of Health Economics

Volumn 20, Issue 6, 2001, Pages 1033-1057

  Cockburn, Iain M ^a,b   Henderson, Rebecca M ^b,c  

^a BOSTON UNIVERSITY   (United States)

^b NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Clinical; Economies of scale; Pharmaceuticals; R D

Indexed keywords

DRUG;

DRUG DEVELOPMENT; ECONOMY OF SCALE; PHARMACEUTICAL INDUSTRY; RESEARCH AND DEVELOPMENT;

ARTICLE; CLINICAL RESEARCH; DRUG INDUSTRY; DRUG RESEARCH; MOTIVATION; PERFORMANCE;

EID: 0034776790     PISSN: 01676296     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-6296(01)00108-4     Document Type: Article

References (23)

1. Innovation in large and small firms: An empirical analysis
2. Economic welfare and the allocation of resources for invention
3. Who does R&D and who patents?
4. Economies of density versus economies of scale: Why trunk and local service airline costs differ
5. Empirical studies of innovation and market structure
6. Research and technical change in the pharmaceutical industry
7. An empirical analysis of scale and scope economies and technical change in an Irish multiproduct banking firm
8. Innovative productivity and returns to scale in the pharmaceutical industry
9. Know-how complementarities and knowledge transfer within firms: The case of R&D
10. Measuring competence? Exploring firm effects in pharmaceutical research
11. Scale, scope and spillovers: The determinants of research productivity in drug discovery
12. Research expenditures and the discovery of new drugs
13. Technological determinants of firm and industry structure
14. Economies of scope
15. The size distribution of innovative firms in the UK: 1945-1983
16. Scale and scope effects on advertising agency costs
17. Economies of scope and the scope of the enterprise
18. Technical change and firm size: The pharmaceutical industry